Scar Injection: Beyond Triamcinolone Acetonide

Authors

  • Vincent Richer, MD, FRCPC

Abstract

Pathological scars, comprising hypertrophic scars and keloids, are both rewarding and challenging to treat in clinical practice. Beyond the cosmetic appearance and the physical reminder of the circumstances of scar formation, patients can also experience itch, pain, or even functional limitations. In many ways, the large number of available treatment options highlight that there is no globally accepted therapeutic ladder for this clinical scenario.   

 

Author Biography

Vincent Richer, MD, FRCPC

Dr. Vincent Richer practices medical and cosmetic dermatology at Pacific Derm in Vancouver. He holds positions as Clinical Assistant Professor and Director of Continuing Medical Education at the University of British Columbia’s Department of Dermatology and Skin Science. He trained at Université de Montréal in medicine and dermatology and completed a fellowship in photobiology and cutaneous laser surgery at UBC.

References

Limmer EE, Glass DA. A review of current keloid management: Mainstay monotherapies and emerging approaches. Dermatol Ther (Heidelb). 2020;10(5):931-948.

Truong K, Prasidha I, Wain T. A systematic review of randomised controlled trials investigating laser assisted drug delivery for the treatment of keloid and hypertrophic scars. Lasers Med Sci. 2021;doi:10.1007/s10103-021-03296-z. Online ahead of print.

Waibel JS, Rudnick A, Shagalov DR, Nicolazzo DM. Update of ablative fractionated lasers to enhance cutaneous topical drug delivery. Adv Ther. 2017;34(8):1840-1849.

Waibel JS, Wulkan AJ, Rudnick A, Daoud A. Treatment of hypertrophic scars using laser-assisted corticosteroid versus laser assisted 5-fluorouracil delivery. Dermatol Surg. 2019;45(3):423-430.

Zhuang Z, Li Y, Wei X. The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis. Burns. 2021;24:S0305-4179(21)00049-8.

Sun P, Lu X, Zhang H, Hu Z. The efficacy of drug injection in the treatment of pathological scar: A network meta-analysis. Aesthetic Plast Surg. 2021;45(2):791-805.

Zhou LL, Richer V. Treating keloids with intralesional 5-fluorouracil and triamcinolone acetonide: Aren’t we there yet? J Cutan Med Surg. 2020;24(2):205-206.

Qiao Z, Yang H, Jin L, Li S, Wang X. The Efficacy and Safety of Botulinum Toxin Injections in Preventing Postoperative Scars and Improving Scar Quality: A Systematic Review and Meta- Analysis. Aesthetic Plast Surg. ePub 2021 Mar 5.

Gamil HD, Khattab FM, El Fawal MM, Eldeep SE. Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions. J Dermatolog Treat. 2020;31(5):535-544.

Abd El-Dayem DH, Nada HA, Hanafy NS, Elsaie ML. Laser-assisted topical steroid application versus steroid injection for treating keloids: A split side study. J Cosmet Dermatol. 2021;20(1):138-142.

Sabry HH, Ibrahim EA, Hamed AM. Assessment of laser-assisted delivery vs intralesional injection of botulinum toxin A in treatment of hypertrophic scars and keloids. Dermatol Ther. 2020;33(6):e13980.

Downloads

Published

2021-08-01

How to Cite

1.
Richer V. Scar Injection: Beyond Triamcinolone Acetonide. Can Dermatol Today [Internet]. 2021 Aug. 1 [cited 2024 Nov. 21];2(3):8–10. Available from: https://canadiandermatologytoday.com/article/view/2-3-richer

Issue

Volume 2, Issue 3, August 2021

Section

Articles